Prenetics Global Limited (PRE)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Sheng Wu Yeung | Co-Founder, Chairperson & CEO | -- | -- | 1979 |
| Dr. Chi Hung Tzang Ph.D. | Co-Founder & Chief Scientific Officer | -- | -- | 1975 |
| Mr. Hoi Chun Lo | Chief Financial Officer | -- | -- | 1986 |
| Ms. Samantha Kwok | Chief of Staff to Group CEO & Vice President of People & Operations | -- | -- | -- |
| Dr. Senthil Kumar Sundaram M.D. | Chief Clinical Officer | -- | -- | 1974 |
| Mr. Joel Neoh | Chief Consumer Officer | -- | -- | 1984 |
| Mr. David Eric Vanderveen | Director & President of Americas | -- | -- | 1969 |
Prenetics Global Limited
- Sector:
- Healthcare
- Industry: Diagnostics & Research
Description
Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes multi-cancer early detection technologies. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests. Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. Additionally, it is involved in the sports distribution activities providing sports nutrition products to fitness facilities. The company operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.
Corporate Governance
Upcoming Events
March 5, 2025 at 1:30 PM UTC
Prenetics Global Limited Earnings Date